{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-292834","form_type":"8-K","ticker":"AVLN","cik":"0001540171","company_name":"Avalyn Pharma Inc.","filed_at":"2026-07-01T21:20:55+00:00","discovered_at":"2026-07-01T21:22:00.418499+00:00","generated_at":"2026-07-01T21:22:06.006648+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Avalyn Pharma expands Boston sublease by ~4,934 sq ft; lease payments rise ~$924k","bullets":["Expands subleased premises from ~8,774 to ~13,708 rentable square feet at 105 W First Street, Boston.","Future minimum lease payments increase by ~$924,000 over the remaining term ending Jan 31, 2029.","Expansion effective upon master landlord's consent; Sublandlord may rescind if consent not received within 30 days.","Base rent for Expansion Premises starts at $28,781.67/month, escalating to $30,534.47/month in final year.","Subtenant gets 2 garage parking passes (up from 1) and use of existing furniture in the expansion space."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-292834","json":"https://secwatch.observer/filing/0001193125-26-292834.json","markdown":"https://secwatch.observer/filing/0001193125-26-292834.md","text":"https://secwatch.observer/filing/0001193125-26-292834.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540171/000119312526292834/0001193125-26-292834-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540171/000119312526292834/ck0001540171-20260629.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-01T21:22:06.006648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}